Printer Friendly

Pneumococcal vaccine.

PNEUMOCOCCAL VACCINE

Pneumonia used to be called "the friend of the aged" in the days before antibiotics, because it was that which finally and quietly terminated life for many in die end stages of other diseases. In this antibiotic era, however, we are inclined not to give it the attention it still deserves.

Pneumococcal pneumonia accounts for 500,000 cases of the bacterial pneumonias seen in this country each year, and although it usually responds to antibiotics, it can be at worst fatal and at best a debilitating disease. Yet only 10-to-20 percent of those at greatest risk for developing the disease are given the vaccine, which is 90 percent effective and whose protection lasts 5-to-10 years. This high-risk group includes persons older than 65; those with such chronic health problems as diabetes, heart disease, and kidney disease, to name just three; health care workers or family members caring for the chronically ill; and children with such chronic pulmonary problems as asthma.

Reactions to the vaccine are minimal or, for many, non-occurring. If you are in any of the above groups, ask your doctor for the vaccine if he has not already offered it.
COPYRIGHT 1991 Benjamin Franklin Literary & Medical Society, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Medical Update
Date:Mar 1, 1991
Words:194
Previous Article:Let them eat cake.
Next Article:Music to some ears.
Topics:


Related Articles
Avoiding the nightmare of drug-resistant pneumococcal pneumonia.
Pneumococcal vaccine: underuse cannot be justified.
Pneumonia Vaccine--Don't Leave Home Without It.
Effectiveness of pneumococcal polysaccharide vaccine for preschool-age children with chronic disease.
Rare systemic dermatologic reaction after pneumococcal vaccine administration. (Case Report).
The prevalence of colonization with drug-resistant pneumococci among adult workers in children's daycare.
Pneumonia & women: pneumonia specialist Orin Levine, PhD, is the first to admit that the disease to which he's devoted his life gets no respect.
Prevenar--pneumococcal conjugate vaccine.
Increasing hospital admissions for pneumonia, England.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters